Journey Medical Corp
DERM
Get informed when a big investor buys or sells
+ FollowMarket Cap$197.06M
Close$
$-5.57
190% downside
Current Fair Value
190% downsideOvervalued by 190% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $197.06 Million |
|---|---|
| Enterprise Value | $195.37 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 1.07 |
| Outstanding Shares | 27,305,028 |
Return
| Return on Equity | -31.10% |
|---|---|
| Return on Assets | -10.47% |
| Return on Invested Capital | -13.41% |
Valuation & Multiples
| P/E Ratio | -19.05 |
|---|---|
| PEG | 42.09 |
| Price to Sales | 3.1 |
| Price to Book Ratio | 6.19 |
| Enterprise Value to Revenue | 3.02 |
| Enterprise Value to EBIT | -27.14 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.83 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-0.03
Average shareholder expectationRevenue Estimate
$20.42 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$18.36 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 10.87%▼ 37.52% |
|---|---|
| Total Invested | $21.01M▼ 62.29% |
| Investors Holding | 4▼ 68.00% |
ESG Score
No data